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when depression was treated as a time-varying covariate basedMultiple measurements of depression predict mortality in a
on periodic follow-up assessments, the level of depressive affectlongitudinal study of chronic hemodialysis outpatients.
was significantly associated with mortality in both single vari-Background. The medical risk factors associated with in-
able and multivariable analyses.creased mortality in hemodialysis (HD) patients are well
Conclusions. Higher levels of depressive affect in ESRDknown, but the psychosocial factors that may affect outcome
have not been clearly defined. One key psychosocial factor, patients treated with HD are associated with increased mortal-
depression, has been considered a predictor of mortality, but ity. The effects of depression on patient survival are of the
previous studies have provided equivocal results regarding the same order of magnitude as medical risk factors. Our findings
association. We sought to determine whether depressive affect using both controls for factors possibly confounded with de-
is associated with mortality in a longitudinal study of end-stage pressive affect in patients with ESRD and time-varying covari-
renal disease (ESRD) patients treated with HD, using multiple ate analyses may explain the inconsistent results of previous
assessments over time. studies of depression and mortality in ESRD patients. Time-
Methods. Two hundred ninety-five outpatients with ESRD varying analyses in longitudinal studies may add power to de-
treated with HD were recruited from three outpatient dialysis fining and sensitivity to establishing the association of psycho-
units in Washington D.C. to participate in a prospective cohort social factors and survival in ESRD patients. The mechanism
study with longitudinal follow-up. Patients were assessed every underlying the relationship of depression and survival and the
six months for up to two years using the Beck Depression effect of interventions to improve depression in HD outpatients
Inventory (BDI), age, serum albumin concentration, Kt/V, and and general medical inpatients should be studied.
protein catabolic rate (PCR). A severity index, previously dem-
onstrated to be a mortality marker, was used to grade medical
comorbidity. The type of dialyzer with which the patient was
The prevalence of depression and its role in mediatingtreated was noted. Patient mortality status was tracked for a
minimum of 20 and a maximum of 60 months after the first survival of patients with end-stage renal disease (ESRD)
interview. Cox proportional hazards models, treating depres- has been highly controversial [1]. Depression has been
sion scores as time-varying covariates in a univariable analysis, shown to be associated with excess mortality in patientsand controlling for age, medical comorbidity, albumin concen-
hospitalized with myocardial infarction [2, 3] and withtration, and dialyzer type and site in multivariable models,
other medical illnesses [4, 5]. Many of the symptoms usedwere used to assess the relative mortality risk.
Results. The mean (6 SD) age of our population at initial to diagnose depression mimic those of medical illnesses,
interview was 54.6 6 14.1 years. The mean PCR was 1.06 6 including uremia [1].
0.27 g/kg/day, and the mean Kt/V was 1.2 6 0.4 at baseline,
Unipolar depression has been projected to be a leadingsuggesting that the patients were well nourished and dialyzed
future cause of morbidity and mortality and the secondcomparably to contemporary U.S. patients. The patients’ mean
BDI at enrollment was 11.4 6 8.1, in the range of mild depres- most common debilitating disease worldwide over the
sion. Patients’ baseline level of depression was not a significant next 20 years, surpassed only by the morbidity of cardio-
predictor of mortality at 38.6 months of follow-up. In contrast, vascular disease in the number of years of productive
life diminished by disability [6, 7]. While several studies
of ESRD patients have shown an association of depres-Key words: chronic renal disease, end-stage renal disease, hemodialy-
sis, depression, Beck Depression Inventory, mortality and dialysis. sion with mortality [1, 8–13], others have not [14–16].
Older studies of the association of depression and mor-
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such as the symptoms of comorbid renal and systemic determined [16]. The dialyzer used to treat each patient
at study entry was noted and categorized as (1) unmodi-diseases. Previous studies also varied widely in their ob-
servation periods. In addition, studies have not assessed fied cellulose or (2) modified cellulose or synthetic, as
previously described [16, 23]. The Karnofsky Perfor-ESRD patients’ depressive affect in a longitudinal fashion.
In a previous study, including a small number of pa- mance Status Scale score was determined as previously
described [18].tients treated with both hemodialysis (HD) and chronic
peritoneal dialysis, we showed that depressive indices The level of depressive symptoms was assessed using
the Beck Depression Inventory (BDI) [24] in patientspredicted survival of patients at one year, but by two
years, medical markers were more powerful predictors at study entry. Thereafter, patients were evaluated every
six months for up to two years using the BDI. Question-of patient survival [13]. We recently studied outcomes
prospectively in a larger number of patients treated with naires were administered in an interview format by
trained personnel. The BDI is a well-validated measureHD for ESRD, and reported that psychosocial factors
measured at baseline, such as perception of the effects of depression, correlating with diagnostic criteria for de-
pression [24, 25]. It has been used frequently to assessof illness and level of social support, were associated with
differential survival. However, we were unable to delin- depression in patients with ESRD [1, 12, 13, 16, 18, 19, 26].
A second measure, the Cognitive Depression Indexeate an expected association of extent of depressive affect
and mortality in this population [16]. Recently, studies (CDI), a subscale of the BDI, is composed of 15 of its
21 items [1, 13, 18, 19, 27] and focuses on thoughts andhave demonstrated the power of longitudinal observa-
tions in explaining survival in ESRD patients treated feelings related to the diagnosis of depression, such as
guilt, disappointment, and failure, excluding its somaticwith HD, using time-varying covariate survival analyses
[17]. We therefore assessed the association of higher items [1, 13, 16, 27]. This scale was used to reduce the
possible confound between symptoms of medical illnesslevels of depressive affect, based on repeated assess-
ments, with mortality in our study population of urban and the somatic components of depression measured in
the BDI [1, 24, 27]. The CDI has previously been highlypatients with ESRD treated with HD, while controlling
correlated with the BDI in ESRD patients [1, 13, 18, 19],for the variation in various potential confounders.
but was unassociated with measures of severity of illness,
nutrition, renal function, and delivery of dialysis [27].
METHODS The number of assessment periods per patient varied
Our patient recruitment techniques and study popula- according to when each patient entered the study and
tion have been extensively described [1, 16, 18, 19]. Re- whether each patient died or left the HD center during
cruitment began September 1, 1992, and concluded March their first three years of follow-up. The longest follow-
31, 1996, and the observation period ended December 31, up for any surviving patient was five years from first
1997. George Washington University Medical Center’s interview to the end of the study, and the shortest was
Ambulatory Dialysis Unit (GWUMC), Howard Univer- 20 months.
sity Medical Center’s Dialysis Unit (HUMC), and the The survival time for each patient was determined by
Washington Veterans Affairs Medical Center Dialysis the number of days between the initial study evaluation
Unit (VAMC), all in Washington D.C. (USA), were the and the end of the study observation period or date of
study sites. The population of the three units was primar- death [16]. Survival status was confirmed using the
ily composed of urban, African American patients. All Health Care Finance Administration database, obtained
patients enrolled in chronic ESRD HD programs at the through ESRD Network 5 (Richmond, VA, USA) for
three units and currently receiving dialysis on an outpa- each patient enrolled in the study [16].
tient basis were eligible for the study, with the exception Cox proportional hazards regression was performed
of HIV-infected patients, patients who had a psychiatric to predict the mortality hazard associated with baseline
diagnosis of psychosis, and patients who scored less than level of depressive affect, controlling for the effects of
23 on a mini-mental status exam [20]. Up to 10% of the variation in patient age, severity coefficient, level of se-
patient population was known to have HIV infection rum albumin concentration, dialyzer type, and site, as
[21]. Informed consent was obtained from all patients previously described [16, 28].
prior to enrollment. The study was approved by the Survival analyses were then conducted using Cox’s
institutional review boards of the three medical centers. proportional hazards regression models, which allow the
Disease severity (age and the presence of comorbid incorporation of time varying covariates [29, 30]. Survival
conditions, including diabetes mellitus) was quantitated statistics were calculated with Proc PHREG from SAS
by the ESRD severity coefficient [13, 16, 18, 19, 22], 6.12 (SAS Institute Inc., Cary, NC, USA) [16, 30] using
previously validated in a large sample of ESRD patients the “exact” method for tied follow-up times [30]. BDI
[22]. The mean of three sequential monthly serum albu- and CDI scores were treated as time-varying covariates,
incorporating up to six patient assessments [29]. Eachmin concentrations after the patients’ enrollment was
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Table 1. Clinical characteristics of the patient population (N 5 295)patient contributed a separate observation spanning the
time from each BDI assessment until the next assessment Mean SD Range
or death or the end of the study. The time-varying form Age years 54.6 14.1 19–84
Diabetes % 42.3of the Cox regression model produces relative risk esti-
Karnofsky score 73.7 17.2 10–100mates of mortality similar in meaning to that of the
Albumin g/dL 3.82 0.49 2.3–5.65
standard Cox regression model [30]. Time-varying mod- Kt/V 1.2 0.4 0.36–1.96
PCR g/kg/day 1.06 0.27 0.49–2.37els have at least two advantages over standard survival
BDI 11.4 8.1 0–47models. First, time-varying models essentially predict
Abbreviations are: PCR, protein catabolic rate; BDI, Beck Depression Inventory.from each assessment point, rather than assuming that
prediction from baseline is sufficient. Second, because
more data points are considered, statistical power may
be greater. The relative risk reported is related to the
g/dL, and the mean arm circumference, performed in
risk set and level of the covariate for the exact time that
85% of enrolled patients, was 30.2 6 5.9 cm, suggesting
each estimate is made, not just to baseline levels.
that the patients were representative of the contempo-All other covariates (age, severity coefficient and se-
rary African American population of the U.S. ESRDrum albumin concentration, dialyzer type, and site) were
program, and were well dialyzed and in an adequatefixed, based on their assessed values at the start of study
nutritional state compared with contemporary popula-enrollment. For each of the two depression measures,
tions [31–33]. The mean baseline BDI score for the entiretwo Cox regression models were fit. The first model used
population was 11.4 6 8.1, in the range of mild depressiononly the depression measure as a predictor. The second
[25]. Depression scores at baseline assessments were notadded covariates, which had previously been shown to
significantly correlated with the patients’ age, severitypredict mortality in this [1, 16, 23] and other populations
coefficient, or serum albumin levels.[17, 23, 31]. In order to enhance interpretability, all con-
One hundred fourteen of the 295 patients died duringtinuous variables used as predictors—BDI and CDI
the study follow-up period. The crude mortality rate wasscores, age, severity coefficient, and albumin—were stan-
0.13 deaths per person year, a rate similar to that found indardized to a standard deviation of 1.0, allowing a com-
other studies of the ESRD population [31]. All patientsparison of the effects of changes in levels of risk factors
received a psychosocial assessment between one and sixacross different parameters in a population, as previously
times (mean 5 2.9 6 1.7 assessments). The longest perioddescribed [16]. Cumulative survival estimates were plot-
between first and last assessments for a patient was 34ted against time for three levels of depression: BDI levels
months.less than 10 (low or nonexistent symptoms), 10 to 15 (mild
There was no significant difference between the meanlevels), and 16 or greater (moderate to severe levels) [25].
baseline BDI scores of patients who died and those whoOne-way analysis of variance was used to assess differ-
survived during the observation period. The mean BDIences between means at different time periods after
score of patients who survived to have three assessmentsstudy enrollment. The a level of tests of survival was
(N 5 122) decreased from 11.4 6 9.0 at baseline to 10.0 60.05. Data are presented as mean 6 SD.
9.2 at the second assessment and 9.2 6 8.3 at the third
assessment, approximately one year after the initial study
RESULTS entry (P 5 0.004).
As in our previous report, the baseline level of de-The total sample surveyed comprised 295 subjects,
pressive affect was not significantly associated with mor-a 60.8% enrollment rate [16]. Less than 10% of HIV-
tality at a longer mean follow-up of 38.6 months (BDI,uninfected, recruited patients were excluded because of
relative risk 5 1.09, 95% CI, 0.92 to 1.29; CDI, relativefailure to pass the mental status exam or presence of
risk 5 1.09, 95% CI, 0.91 to 1.31; Table 2) [16]. For thepsychosis. The median follow-up time from the first inter-
next step in the survival analysis, survival was predictedview to patients’ death or the end of the observation
using each of the two depression measures in separateperiod was 38.6 months. More than 92% of our patient
models as a time-varying covariate. The BDI score pre-sample was comprised of African Americans. Twenty-
dicted survival with an estimated relative risk of 1.24eight percent of the patients were female, and 42.3%
(95% CI, 1.05 to 1.46, P 5 0.01), indicating that an 8.1had diabetes mellitus (Table 1). The mean age of our
point (1 SD) increment in BDI scores was associatedpatient population was 54.6 6 14.1 years. Patients had
with a 24% higher risk of death. A similar, but smallerbeen treated with HD for mean and median times of
effect was noted when CDI scores were assessed (relative30.2 6 47.5 and 12.4 months, respectively, at the study
risk 5 1.18, 95% CI, 1.00 to 1.38, P 5 0.05).entry. The patients’ mean protein catabolic rate (PCR)
The analyses were repeated with the control variableswas 1.06 6 0.27 g/kg/day. The mean Kt/V was 1.2 6 0.4.
The mean serum albumin concentration was 3.82 6 0.49 added. Both BDI and CDI scores remained significant
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Table 2. Depressive affect as a predictor of mortality in ESRD
patients treated with hemodialysis
RR (CI) P value
Baseline Beck Depression 1.09 (0.92, 1.29) NS
Baseline Cognitive Depression 1.09 (0.91, 1.31) NS
Time-varying Beck Depression 1.24 (1.05, 1.46) 0.01
Time-varying Cognitive Depression 1.18 (1.00, 1.38) 0.05
Adjusted Time-varying Beck Depression 1.32 (1.13, 1.55) 0.0006
Adjusted Time-varying Cognitive
Depression 1.23 (1.05, 1.43) 0.009
Data are adjusted and unadjusted for age, severity, serum albumin concentra-
tion, dialyzer type, and site. All relative risks have been standardized to a standard
deviation of 1.0 (based on the SD’s of the 295 patients). Analyses for Time-
varying Beck and Cognitive Depression scores are univariate. All adjusted analy-
ses are controlled for age, severity, serum albumin concentration, dialyzer type
and site. CI is confidence interval.
predictors, with an estimated 32 and 23% higher risk of
death being associated with a one standard deviation
increment in BDI and CDI scores, respectively (95%
CI, 1.13 to 1.55, P 5 0.0006, and 1.05 to 1.43, P 5 0.009,
respectively).
Cumulative survival estimates were plotted against
time for the three clinically delineated levels of depres-
sion: BDI levels less than 10 (low or nonexistent symp-
Fig. 1. Association between the level of depressive affect and survivaltoms), 10 to 15 (mild levels), and 16 or greater (moderate
in 295 patients with end-stage renal disease treated with hemodialysisto severe levels) [25] using BDI and CDI measurements followed and assessed longitudinally. Cumulative survival estimates
pooled for each patient from each observation period were plotted against time for three levels of depression: BDI levels less
than 10 (low or nonexistent symptoms, thin line), 10 to 15 (mild levels,(Fig. 1). Patients with mild symptoms or greater levels
medium line), and 16 or greater (moderate to severe levels, broadof depressive affect were at greater mortality risk than line). For the time-varying proportional hazards modeling, each patient
patients with low or nonexistent symptoms, although contributed a separate observation spanning the time from each BDI
assessment until the next assessment or death or the end of the study.there was no difference in risk between patients with
The cumulative survival estimates plotted are based on the same poolingmild or more severe levels of depressive affect. of observation periods. Patients with depression had greater mortality
risk than patients without symptoms of depressive affect, although there
was no difference in risk between patients with mild or more severe
DISCUSSION symptom levels.
Previous studies of the association of depressive affect
and survival have yielded contradictory results. Early
with mortality, although Christensen et al found percep-studies may have assessed highly selected populations,
tion of social support predicted survival, as we did [16].dialyzed less intensively than current guidelines man-
On the other hand, the deleterious effects of depres-date, with dialysis membranes that did not provide opti-
sion, measured at the outset, have been often found inmal clearance and biocompatibility profiles [8–11]. In
older studies, usually without fully controlling for varia-our previous analysis of this population, using a shorter,
tions in medical comorbidity, nutrition, or the effects of26-month average follow-up period, we were unable to
dialytic interventions [8–12]. Foster, Cohn, and McKeg-show an association of depressive affect at baseline with
ney showed that HD patients who exhibited less evi-survival, when age, severity of comorbid illness, serum
dence of general psychopathology during initial inter-albumin concentration (as a nutritional marker), dialyzer
views had improved survival over a two-year observationtype, and site were used as control variables [16]. Like-
period [8]. Wai et al found that at an 18-month follow-wise, two other recent studies of ESRD patients using
up of home dialysis patients, younger age, lower depres-relatively long-term follow-ups provided similar results
sion and stress scores, and higher serum albumin concen-[14, 15]. Devins et al (four year follow-up) [14] and Chris-
trations were associated with improved patient survivaltensen et al (average 44 month average follow-up) [15]
[9]. Likewise, Burton et al studied home dialysis patientsboth failed to find a relationship between depression and
starting ESRD therapy, measuring psychological, physi-mortality. These recent studies, using a wide range of
cal, social function and support, personality profiles, andmedical and psychosocial control variables (but not dia-
economic well-being parameters [10]. After a two-yearlytic parameters) and sophisticated survival analyses,
suggested baseline level of depression was not associated period, the mean depression score was lower in the group
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of survivors compared with subjects who died shortly Time-varying analyses allow for multiple time point
after the initial interview. Ziarnik, Freeman, and Sher- assessments of level of depression and can capture both
rard also noted an association of depression with poorer stable levels of depression and dynamic changes in de-
one-year survival, but not longer survival [11]. Shulman, pression. Patients may adapt to a stressor or their affect
Price, and Spinelli demonstrated that the BDI score and may improve, resulting in increased survival, while other
age, which were unrelated at original evaluation, were patients whose mood has remained negative over a long
the significant predictors of mortality in their ESRD period of time or worsened over a short period of time
population [12]. Survival differences between ESRD pa- may succumb to a combination of the psychologic and
tients with high and low levels of depression were maxi- medical disorders. A recent study by Friend et al, also
mal over the first two years of observation [12]. using a time-dependent approach, demonstrated that de-
We demonstrated similar findings in an earlier study pression predicts changes in serum albumin levels in
of a different population of patients from a similar urban patients with ESRD, but the converse does not occur
catchment group [13]. These latter studies suggested that [34]. Such data not only underscore the importance of
depression might mediate poor survival for HD patients, controlling analyses for medical factors, but provide pos-
but over shorter observation periods. These data, plus sible mechanisms for mediating the adverse effects of
our initial visual inspection of the survival curves, lead depressive affect on patient outcomes, such as effects
us to perform a time-varying covariate analysis of the on nutrition and the immune system, as we previously
effects of depression on HD patients’ survival. Time- hypothesized [1]. Alternatively, depressive affect may
varying covariate analyses provide an integrated, longi- be a marker for unmeasured mortality risk factors, such
tudinal assessment of the effect of a given change in a as maladaptive health behaviors [1, 5, 16]. However, our
parameter over time on a specified outcome. Recent anal- findings suggest that the symptom of depressive affect,
yses have demonstrated the power of time-varying analy- rather than solely a marker event, may be the locus for
ses to delineate important associations of change in se- intervention in an outpatient setting. Such notions would
rum albumin over time with survival in HD patients [17]. suggest that surveillance of ESRD patients for depres-
The current analysis provides a more realistic model, since sion would be useful on an ongoing basis.
it uses multiple and recent levels of depressive symptoms, Although the observed magnitude of the association
rather than a single baseline value to test associations between depression scores and survival is modest, these
with survival over varying periods of time. The magni- levels are of the same order of magnitude as effects of
tude and effects of unipolar depression may be experi- medical predictors of outcome delineated in other stud-
enced with intensity during a relatively short period. ies [16, 31]. If the observed effect size were confirmedAlternatively, patients with a unipolar depressive illness
in a clinical trial, the public health consequences couldmay experience high levels of depression with relatively
be substantial. For example, a treatment capable of pro-few changes in magnitude. Time-varying analyses can
ducing a 8.1-point drop in BDI scores among moderatelydistinguish between these two patterns. In addition, this
or severely depressed patients (an achievable effect) [35]type of analysis is especially important with a parameter
could lead to an estimated 32% increase in survival timelikely to be variable, in contrast to other mortality mark-
among HD patients.ers in HD patients, such as age, gender, and ethnic back-
Our results do not necessarily demonstrate causality.ground, which are perforce immutable, and it takes ad-
It is possible that medically related deterioration amongvantage of the longitudinal design of our study with
some patients leads to greater depressive symptoms priormultiple measurements of depressive affect.
to death. Notions of causality can only be tested in a trialStudies have demonstrated that depression may pre-
using a clinical intervention. The results, however, aredict survival in patients hospitalized with a myocardial
particularly applicable to a group of patients, such as olderinfarction [2, 3] or with a general medical problem [4, 5].
African Americans, who may be specifically at risk forIn a patient with a chronic illness, such as ESRD, treated
developing depressive symptoms [36, 37] and who areas an outpatient, such signal events as hospitalizations
overrepresented in the U.S. ESRD program [31]. Theor myocardial infarctions are not useful for planning
findings become trenchant when considered in the lightpreventive interventions. High levels of depressive affect
that depression is a problem of the older population [36]in chronically ill outpatients may develop at any time.
and is relatively common in the ESRD population [37],Depression may be a reaction to a particular stressor, such
and that the mean age of the US dialysis population isas loss of a loved one, or a medical setback, or may develop
increasing at a rapid rate [31]. Our findings must there-gradually as a function of highly negative perceptions of
fore be replicated in more diverse ethnic populationsthe effects of the illness on functioning and quality of life.
within the ESRD program. The findings, however, haveOur findings from this and previous studies suggest that
important implications for treatment of all HD patients:when the patient experiences high levels of depression,
A high level of self-reported depression may indicate “aeven after an initial assessment, a period of time exists
window of opportunity” during which psychopharmaco-during which depression may have deleterious mortality
consequences. logical or cognitive therapy might enhance patient sur-
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